Today, the SVP, Corporate & Business Dev of NanoString Tech (NSTG), David Ghesquiere, sold shares of NSTG for $204.4K.
See today’s analyst top recommended stocks >>
Based on NanoString Tech’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $27.69 million and GAAP net loss of $21.9 million. In comparison, last year the company earned revenue of $23.09 million and had a GAAP net loss of $19.2 million. Currently, NanoString Tech has an average volume of 230.9K. The Company has a Price to Book ratio of 10.1761.
The insider sentiment on NanoString Tech has been negative according to 36 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway.
